Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2012 Oct;23 Suppl 7:vii72-7. doi: 10.1093/annonc/mds228.
No abstract available

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Disease Management
  • Drug Resistance, Neoplasm
  • Genes, abl
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Molecular Targeted Therapy
  • Prognosis
  • Protein Kinase Inhibitors / therapeutic use
  • Risk
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors